Beximco Pharma

Last updated
Beximco Pharmaceuticals Ltd
Company type Limited
DSE:  BXPHARMA
LSE:  BXP
Industry Pharmaceutical
Founded1980
Headquarters Dhanmondi, Dhaka, Bangladesh
Key people
Iqbal Ahmed (Managing Director)
RevenueIncrease2.svg3926.7 crore (US$330 million) (2023) [1]
Increase2.svg691.2 crore (US$58 million) (2023) [1]
Decrease2.svg461.4 crore (US$39 million) (2023) [1]
Number of employees
4,523 (2019) [2]
Website Official Website

Beximco Pharmaceuticals Ltd, also known as Beximco Pharma (stylised as BEXIMCO PHARMA) is a Bangladeshi multinational pharmaceutical company. [3] It is a part of Bangladesh Export Import Company Limited (BEXIMCO). [4]

Contents

History

Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States. [5] Today, Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets. It was the first drug company from Bangladesh to sell its products in the US. [6]

In May 2020, the company introduced the world's first generic remdesivir for COVID-19 treatment. [7] [8] [9] Beximco Pharma became the first company to obtain production and marketing authorization for molnupiravir, the first and only specific oral anti-covid drug in Bangladesh along with Eskayef Pharmaceuticals. [10] [11] Beximco Pharma's branded generic version of molnupiravir is being marketed as Emorivir. [12]

Factories

Beximco Pharma manufacturing facilities are spread across a 20-acre (81,000 m2) site located in Dhaka, Bangladesh. [13] The facilities consist of a number of purpose-built plants, including a new Oral Solid Dosage (OSD) plant. The site includes manufacturing facilities as well as a research laboratory and a number of warehouses. The plant and machinery of the facilities were designed, produced and installed by partners from Germany, Switzerland, Sweden, Italy and the United Kingdom, amongst others.

Exports

In August 2007, Beximco exported its medicines to the Philippines, the 5th country of the 10-member Association of South East Asian Nations (ASEAN) to import Beximco's drugs.

Related Research Articles

<span class="mw-page-title-main">Pharmaceutical industry</span> Industry involved with discovery, development, production and marketing of drugs

The pharmaceutical industry is an industry involved in medicine that discovers, develops, produces, and markets pharmaceutical goods for use as drugs that function by being administered to patients using such medications with the goal of curing or preventing disease. Pharmaceutical companies may deal in "generic" medications and medical devices without the involvement of intellectual property, in "brand" materials is specifically tied to a given company's history, or in both within different contexts. The industry's has various subdivisions are all subject to a variety of laws and regulations that govern entire financial processes including the patenting, efficacy testing, safety evaluation, and marketing of these drugs. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020, in total, and this showed a compound annual growth rate (CAGR) of 1.8% given the results of recent events.

<span class="mw-page-title-main">Cipla</span> Indian multinational pharmaceutical company

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

<span class="mw-page-title-main">Gilead Sciences</span> American pharmaceutical company

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the Nasdaq-100 and the S&P 100.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

Bangladesh Export Import Company Limited, commonly known by its trade name BEXIMCO, is a Bangladeshi multinational conglomerate holding company, headquartered in Dhaka, Bangladesh. It was founded in the early 1970s.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Hetero Drugs</span> An Indian pharmaceutical company

Hetero Drugs is an Indian pharmaceutical company and the world's largest producer of anti-retroviral drugs. Hetero's business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.

<span class="mw-page-title-main">Square Pharmaceuticals</span> Bangladeshi pharmaceutical company

Square Pharmaceuticals Ltd. is a Bangladeshi multinational pharmaceutical company. It was founded in 1958 by Samson H. Chowdhury along with three of his friends PK Saha, Kazi Harunur Roshid and Radhabinod Rai as a private firm. It went public in 1991 and is listed on the Dhaka Stock Exchange and on the Chittagong Stock Exchange Square Pharmaceutical started to export different antibiotics and medicine across the world from 1987. Now it exports its medicine to 36 countries of the world.

<span class="mw-page-title-main">Zydus Lifesciences</span> Indian multinational pharmaceutical company

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020.

Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

Eskayef Pharmaceuticals Ltd., also known as SK+F, is a pharmaceutical company in Bangladesh. It belongs to the Transcom Group. Simeen Rahman is the Managing Director and CEO of the company.

<span class="mw-page-title-main">Incepta Pharmaceuticals</span> Bangladeshi pharmaceutical company

Incepta Pharmaceuticals Limited is a Bangladeshi pharmaceutical company based in Dhaka that manufactures and markets generic drugs and vaccines. Abdul Muktadir is the chairman of the company.

Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals.

<span class="mw-page-title-main">Intas Pharmaceuticals</span> Indian multinational pharmaceutical company

Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing. It has 22 manufacturing plants, 17 in India and the rest in Greece, United Kingdom and Mexico. In the financial year 2019, 69% of the company's revenue came from international markets while 31% came from India. Its market presence is in more than 100+ countries.

<span class="mw-page-title-main">Aspen Pharmacare</span> Major pharmaceutical company in South Africa

Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange (JSE) in 1998, and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals (ARVs) and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union.

<span class="mw-page-title-main">Salman F Rahman</span> Former member of Jatiya Sangsad

Salman Fazlur Rahman, commonly known as Salman F Rahman, is a Bangladeshi businessman and a former member of the Jatiya Sangsad representing Dhaka-1 constituency. He held the position of private industry and investment adviser to the former Prime Minister of Bangladesh, Sheikh Hasina, with the status of a cabinet minister. Prior to this, he was her private sector development affairs adviser.

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. In fiscal year 2020, it generated over $3 billion in annual revenue.

Beacon Pharmaceuticals PLC is a Bangladeshi pharmaceutical company that develops generic version of medications.

<span class="mw-page-title-main">Molnupiravir</span> Antiviral medication

Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID‑19 in those infected by SARS-CoV-2. It is taken by mouth.

Square Group is a Bangladeshi diversified multinantional conglomerate based in Dhaka. Samuel S Chowdhury is the chairman and Tapan Chowdhury is managing director of Square Group. Square Group has 60 thousand employees.

References

  1. 1 2 3 "Beximco Pharmaceuticals Ltd". WSJ. Retrieved 18 January 2024.
  2. "Beximco Pharma Annual Report 2018-19" (PDF). Retrieved 23 December 2019.
  3. "BD firm plans to export version of Tamiflu". Daily Times . 5 April 2006. Archived from the original on 6 June 2011. Retrieved 8 March 2008.
  4. "Bangladesh forays into US market with Beximco Pharma". bdnews24.com . Retrieved 3 October 2016.
  5. "Beximco Pharma Q3 revenue up". The Pharma Letter. Retrieved 3 October 2016.
  6. "US FDA approves Beximco Pharma's blood pressure drug". Dhaka Tribune . Archived from the original on 30 September 2016. Retrieved 3 October 2016.
  7. "Beximco introduces remdesivir for Covid-19 treatment". The Daily Star. 21 May 2020. Retrieved 24 May 2020.
  8. "Beximco Pharma introduces world's first generic Remdesivir for COVID-19 treatment". The Financial Express . Dhaka . Retrieved 24 May 2020.
  9. Siddiqui, Zeba (5 May 2020). "Exclusive: Bangladesh's Beximco to begin producing COVID-19 drug remdesivir - COO". Reuters . Retrieved 6 March 2021.
  10. Pilla, Viswanath (December 30, 2021). "Bangladesh drug maker Beximco launches world's first generic of Pfizer's COVID antiviral". The Economic Times . Retrieved June 26, 2024.
  11. "Beximco Pharma gets license for oral anti-Covid drug". The Business Standard . January 20, 2022. Retrieved June 26, 2024.
  12. "Merck's COVID-19 pill molnupiravir hits Bangladesh markets". The Financial Express . June 26, 2024. Retrieved June 26, 2024.
  13. "Beximco Pharma's Q3 profits soar 51%". The Daily Star. April 30, 2024. Retrieved June 26, 2024.